Aerie Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Aerie Pharmaceuticals

Access the complete profile.

Aerie Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	550 Hills Dr Fl 310 Bedminster, NJ 07921

Aerie Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Aerie Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Aerie Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Aerie Pharmaceuticals is a publicly traded company on NGM using the ticker symbol AERI. Detailed information on company financials and operating reports can be found here: NGM: AERI

Aerie Pharmaceuticals Annual Revenue and Growth Rate

Aerie Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Aerie Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

Aerie Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 23, 2014	5	100%	$125 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Aerie Pharmaceuticals is developing and marketing. Aerie Pharmaceuticals doesn't have any recent trademark applications, indicating Aerie Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ONCE-DAILY ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension	03/29/2019
ROCKLATAN (NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% Pharmaceutical preparations for the treatment of glaucoma and ocular hypertension	03/29/2019
ROCKLATAN (NETARSUDIL/LATANOPROST OPHTHALMIC SOLUTION) 0.02%/0.005% Pharmaceutical preparations for the treatment of glaucoma and hypertension	02/07/2019

See all trademarks and details in the Full Report.

Market Share of Aerie Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Aerie Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Aerie Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ERG HOLDING	New Providence, NJ	100
ZELTIQ AESTHETICS	Madison, NJ	60
IMMUNOMEDICS	Morris Plains, NJ	37
ADC THERAPEUTICS AMERICA	New Providence, NJ	26
CELULARITY	Florham Park, NJ	24
COVIS PHARMA GMBH	Berkeley Heights, NJ	12

Future Competition: Aerie Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Aerie Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)